Key result
Stem cell exosomes show promise as cell-free therapy to overcome poor cell engraftment in CVD.
Answers are grounded in this paper and cite their sources.
Stem cell therapy provides immense hope for regenerating the pathological heart, yet has been marred by issues surrounding the effectiveness, unclear mechanisms, and survival of the donated cell population in the ischemic myocardial milieu. Poor survival and engraftment coupled to inadequate cardiac commitment of the adoptively transferred stem cells compromises the improvement in cardiac function. Various alternative approaches to enhance the efficacy of stem cell therapies and to overcome issues with cell therapy have been used with varied success. Cell-free components, such as exosomes enriched in proteins, messenger RNAs, and miRs characteristic of parental stem cells, represent a potential approach for treating cardiovascular diseases. Recently, exosomes from different kinds of stem cells have been effectively used to promote cardiac function in the pathological heart. The aim of this review is to summarize current research efforts on stem cell exosomes, including their potential benefits and limitations to develop a potentially viable therapy for cardiovascular problems.
No takes yet. Share an insight, caveat, or question.
Kishore et al. (2016) conducted a review in Cardiovascular diseases. Stem cell exosomes was evaluated. Stem cell exosomes offer a promising cell-free therapeutic approach for cardiovascular diseases, potentially overcoming the poor survival and engraftment issues associated with cell-based therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: